Documentary About Andy Whitfield Seeking Funds to Finish Movie

Fans of Andy Whitfield and fans of Spartacus: Blood and Sand , the show Whitfield starred in before he succumbed to non-Hodgkin's lymphoma, are being asked by a documentary filmmaker to make donations to help him finish a documentary about Whitfield's battle with non-Hodgkin's lymphoma called Be Here Now according to an article at TVGuide.com.

In September 2011, Andy Whitfield died at the age of 39. He had been diagnosed with NHL just a year and a half after his diagnosis.

He underwent treatment and things looked good, but unfortunately, his disease proved refractory. He was given very low chances of survival after front-line therapy failed.

Filming his search for treatment

Whitfield and his wife Vashti therefore got together with filmmaker Lilibet Foster in an attempt to chronicle his struggle with the disease while he explored his medical and alternative healing options in Australia, New Zealand and India.

Foster and the other filmmakers need fans' help to raise the remaining funds needed to finish editing the film and they are appealing to both Spartacus: Blood and Sand , and Whitfield's fans to donate to the film through kickstarter.com.

The fundraising page at kickstater.com reads,

"Be Here Now transcends the subject of cancer and becomes a universal life-lesson about living fearlessly, going for your dreams, embracing each moment and living in the present - despite the potential outcome."

The trailer can be viewed below.

Source: Seattle PI

Photo by Gage Skidmore

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap